Skip to main content

Psoriatic arthritis

      Low uveitis rates in patients with axial spondyloarthritis and psoriatic arthritis treated with bimekizumab (BKZ) over t
      Low uveitis rates in patients with axial spondyloarthritis and psoriatic arthritis treated with bimekizumab (BKZ) over the long term. Key findings: - AxSpA: 3.7% incidence (1.3/100 PY) with BKZ. - PsA: Only 0.2% incidence (0.1/100 PY). - All events were mild/moderate, with no… https://t.co/jkUwHJk3FJ https://t.co/gTcCzeC88e
      Abstract 1912: Time to close the gaps in #PsA care
      RISE Registry reveals:
      - higher disease activity in the South
      - mor
      1 month 2 weeks ago
      Abstract 1912: Time to close the gaps in #PsA care RISE Registry reveals: - higher disease activity in the South - more oral steroids + csDMARDs, fewer bDMARDs, and more comorbidities in the Midwest @RheumNow #ACR24
      Using longitudinal claims data, this study explores the safety of non-conventional combination targeted therapy in adult
      Using longitudinal claims data, this study explores the safety of non-conventional combination targeted therapy in adults with psoriatic arthritis (PsA). Key findings: - 42,821 PsA patients analyzed; only 1.1% on combination therapy. - Increased risk of serious infections:… https://t.co/Jghmz9lkLd https://t.co/YqwJlTKcEi
      Improving the Value of Musculoskeletal Ultrasound in Rheumatology Care #ACR24

      MSUS has emerged as a powerful asset in r
      1 month 2 weeks ago
      Improving the Value of Musculoskeletal Ultrasound in Rheumatology Care #ACR24 MSUS has emerged as a powerful asset in rheumatology, providing a real-time, non-invasive, and cost-effective solution for diagnosing and managing inflammatory arthritis conditions such as RA and PsA.… https://t.co/iH9IZmHhSz https://t.co/am5LoBCdpe
      Mental health, sex, and comorbidities are key factors in determining recalcitrant psoriatic arthritis (PsA).
      Key finding
      Mental health, sex, and comorbidities are key factors in determining recalcitrant psoriatic arthritis (PsA). Key findings: - 21.7% of patients required ≥4 biologic/targeted synthetic DMARDs. - Female patients and those with depression were more likely to be recalcitrant. - No… https://t.co/I9YYoRnLwh https://t.co/VtnPceVLOZ
      A Bayesian Network Meta-analysis Phase II/III/IV, placebo-controlled, randomised clinical trials and long-term extension
      A Bayesian Network Meta-analysis Phase II/III/IV, placebo-controlled, randomised clinical trials and long-term extension studies of JAKi and TNFi, in adults with RA, PsO, PsA, axial spondyloarthritis axSpA and IBD showed the following: - TNFi was associated with a significantly… https://t.co/FWHgemEAvG https://t.co/3D0nldwmwA
      📢Late-breaking #2003🔑 Cappelli et al @jhrheumatology finds hip OA is NOT a significant risk factor for #ICI-IA
      1 month 2 weeks ago

      📢Late-breaking #2003 🔑 Cappelli et al @jhrheumatology finds hip OA is NOT a significant risk factor for #ICI-IA 🔴#ICI-IA linked to lower mortality #ACR24 #ACRBest @RheumNow

      Post hoc analysis of SPIRIT H2H evaluated nail involvement as a measure of ttnt response in PsA.
      -Pts with nail involvem
      1 month 2 weeks ago
      Post hoc analysis of SPIRIT H2H evaluated nail involvement as a measure of ttnt response in PsA. -Pts with nail involvement treated with IXE or ADA had higher SJC and TJC improvement vs those without involvement at W12, W24 and W52. -IXE achieved rapid response for DAPSA-LDA as… https://t.co/SR36qCthQo https://t.co/hI3tD5hATJ
      ×